https://www.selleckchem.com/products/gne-781.html
92, sensitivity of 0.84 and a specificity of 0.97. When tested in a blinded fashion, the device recognized 19 out of 29 LC CR patients (=65.5%) as LC-positive, of which only five developed recurrent LC later on (after 18.6 months ± 9.02; mean value ± SD). Unfortunately, the algorithm also recognized 11 of 24 COPD patients as being LC positive (with only one of the 24 COPD patients developing LC 56 months after the measurement). CONCLUSION The Aeonose® revealed some potential in distinguishing LC from HC, however, with low specificity wh
Like
Comment
Share
